Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series
Journal of Drugs in Dermatology · 01.07.2026 · 25 (7) · 659-660
DOI: 10.36849/jdd.9458 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.06.2026. Verfasst von Lenique Kl Huggins und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acneiform Eruptions, Antineoplastic Agents, Hormonal, Aromatase Inhibitors, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Huggins, L. K., Manjunath, J., Alorainy, M., Leventhal, J. S., & Deverapalli, S. (2026). Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series. Journal of Drugs in Dermatology, 25(7), 659-660. https://doi.org/10.36849/jdd.9458
Vancouver
Huggins LK, Manjunath J, Alorainy M, Leventhal JS, Deverapalli S. Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series. Journal of Drugs in Dermatology. 2026;25(7):659-660. doi:10.36849/jdd.9458
BibTeX
@article{Huggins2026,
author = {Huggins, Lenique Kl and Manjunath, Jaya and Alorainy, May and Leventhal, Jonathan S and Deverapalli, Sandhya},
title = {Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {7},
pages = {659--660},
doi = {10.36849/jdd.9458}
}
EUVIMED